Smith & Nephew plc (LON:SN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the six research firms that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have covered the stock in the last year is GBX 1,444.40 ($17.58).
A number of research firms recently issued reports on SN. Barclays reissued an “underweight” rating and set a GBX 1,200 ($14.60) target price on shares of Smith & Nephew in a research report on Monday, October 2nd. JPMorgan Chase & Co. reissued a “neutral” rating on shares of Smith & Nephew in a research report on Thursday, July 20th.
Smith & Nephew Stock Up 2.0 %
Insiders Place Their Bets
In related news, insider Roberto Quarta purchased 5,513 shares of the firm’s stock in a transaction on Wednesday, August 23rd. The stock was purchased at an average price of GBX 1,067 ($12.98) per share, for a total transaction of £58,823.71 ($71,579.11). 0.22% of the stock is owned by company insiders.
Smith & Nephew Company Profile
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. The company operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures.
- Five stocks we like better than Smith & Nephew
- Conference Calls and Individual Investors
- MarketBeat Week in Review – 10/30 – 11/3
- How to Invest in Semiconductors
- Shocking uranium play that hedge funds kept hidden
- What Are Utility Stocks? An Overview of the Utilities Sector
- Dependable dividends: Why utility stocks are on fire
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.